|
|
Article: The clinical and economic benefits of PSA and fPSA testing.(prostate specific antigen and free PSA)
- Article from:
- Medical Laboratory Observer
- Article date:
- March 1, 2001
- Author:
CopyrightCOPYRIGHT 2001 Nelson Publishing. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Researchers believe the latest FDA-approved assays for measuring PSA and fPSA--which provide accurate, inexpensive, and timely results--will continue to play an increasingly vital role in the diagnosis and treatment of prostate cancer.
Prostate specific antigen (PSA) and free PSA (fPSA) assays are invaluable clinical tools in the healthcare arena. When used in conjunction with the digital rectal exam (DRE), these tests provide cost--effective, timely results that provide physicians with the evidence necessary to distinguish between malignant and benign prostatic conditions. The early diagnoses afforded by these assays facilitate prompt, curative treatment, ...